Prefilled Syringes Market - Global Forecast To 2030
| 出版年月 | 2024年7月 |
| ページ数 | 293 |
| 図表数 | 302 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The prefilled syringes market is projected to reach USD 13.1 billion by 2030 from USD 7.1 billion in 2024, at a CAGR of 10.8% during the forecast period.
プレフィルドシリンジ市場は、予測期間中のCAGR 10.8%で、2024年の71億米ドルから2030年までに131億米ドルに達すると予測されています。
The prefilled syringes market has had strong growth due to a number of factors such as the rising incidences of chronic diseases like diabetes, rheumatoid arthritis, and cardiovascular disorders. Moreover, prefilled syringes make it easier to administer medications precisely and consistently to patients with chronic conditions, by providing ready-to-use doses that improve patient compliance and lower the possibility of dosage errors. Additionally, the growing trend of self-administration has also played a major role in the market’s growth. Prefilled syringes are preferred by patients due to their comfort and ease of use, as they eliminate the need for dose measurement, hence improving safety and lowering the danger of contamination.
“By type, conventional prefilled syringes segment is expected to have the largest market share in the prefilled syringes market.”
Based on the type, the conventional prefilled syringes segment is expected to dominate the the prefilled syringes market due to several factors. Their ready-to-use nature and pre-measured doses enhance convenience and safety by reducing preparation time and dosing errors. They lower contamination risks and needle stick injuries through advanced safety features. Prefilled syringes improve patient compliance, particularly for chronic conditions, by being user-friendly and encouraging adherence to treatment regimens. Their versatility in therapeutic applications, especially for biologics and chronic disease treatments, coupled with the growing prevalence of such conditions, further drive their market dominance.
“By material, glass prefilled syringes segment is expected to have the largest market share in the prefilled syringes market.”
Based on material, the glass prefilled syringe segment is expected to hold the largest market share in the prefilled syringes market. Their superior chemical inertness ensures drug stability and reduces the risk of interactions between the drug and the container, making them ideal for a wide range of pharmaceutical applications. Additionally, glass syringes offer high visibility, allowing for easy inspection of the drug for particulates and discoloration, which is critical for quality control and patient safety. As a result, pharmaceutical companies and healthcare providers prefer glass prefilled syringes for their reliability, safety, and efficiency in drug delivery.
“By design, single-chamber prefilled syringes segment is expected to have the largest market share in the prefilled syringes market.”
Based on design, the single-chamber prefilled syringe segment accounted for the largest market share of the prefilled syringes market due to their convenience, safety, and efficiency in drug administration. These syringes, which come pre-loaded with a single dose of medication, minimize the risk of dosing errors and contamination, enhancing patient safety. They streamline the injection process, making it quicker and easier for healthcare providers and patients, thereby improving compliance and treatment outcomes. Moroever, their widespread adoption in various therapeutic areas, particularly in chronic disease management and emergency care, further drives growth in the market.
“By application, cancer segment is expected to have the largest market share in the prefilled syringes market.”
By application, the cancer segment is expected to hold the largest market share due to the increasing prevalence of cancer globally and the rising need for advanced drug delivery systems. Prefilled syringes offer significant advantages for cancer treatment, including precise dosing, reduced risk of contamination, and enhanced patient safety and compliance. As cancer treatments often involve complex medication regimens requiring regular and accurate administration, the convenience and reliability of prefilled syringes become critical. Additionally, advancements in biologics and targeted therapies, which are frequently used in oncology, further drive the demand for prefilled syringes, making the cancer segment the dominant application area in this market.
“By region, North American region is expected to have the largest market share in the prefilled syringes market.”
North America to register for the highest share of the prefilled syringes market during the forecast period due to several factors. These include a well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and a significant focus on patient safety and convenience. Moreover, the region benefits from robust regulatory frameworks that encourage the adoption of pre-filled syringes by ensuring stringent quality standards and safety measures. Additionally, increasing incidences of chronic diseases requiring regular injections, coupled with rising healthcare expenditures, contribute to the growing demand for pre-filled syringes in North America. The presence of major pharmaceutical companies and biotechnology firms further enhances market growth through extensive research and development activities aimed at improving drug delivery systems.
A breakdown of the primary participants (supply-side) for the prefilled syringes market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
- By Designation: C-level–20%, Director Level–35%, and Others–45%
- By Region: North America–27%, Europe–25%, Asia Pacific–30%, Latin America- 8%, Middle East & Africa-10% .
Prominent players in the prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), and West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Meidcal international Co., Ltd. (China), Credence MedSystems, Inc.(US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymedicure (India), MedXL (Canada), Sharps Technology, Inc.(US), Fresenius Kabi (US), DBM S.R.L. (Italy), Taisei Kako Co.,Ltd (Japan), Shandong Province Medicinal Glass Co., Ltd.(China), SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD (Japan), J.O. PHARMA CO., LTD. (Japan), BMIKOREA (Korea), B. Braun SE ( Germany), and Al Shifa Medical Products Co. (Saudi Arabia).
Research Coverage:
The report analyzes the prefilled syringes market and aims at estimating the market size and future growth potential of this market based on various segments such as type, material, design, application, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall prefilled syringes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (increasing chronic diseases, incereasing biologics and biosimilars, and technological advancements), restraints (product recalls, and stringent government regulations), opportunities (increasing prevalence of self-administration of injectables and increasing regulatory support) and challenges (presence of alternative drug delivery methods, and infections associated with needlestick injuries)
- Market Penetration: It includes extensive information on products offered by the major players in the global the prefilled syringes market. The report includes various segments in type, material, design, application, and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global prefilled syringes market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by type, materila, design, application, and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the prefilled syringes market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global prefilled syringes market.
Table of Contents
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS & EXCLUSIONS 25
1.3 STUDY SCOPE 26
1.4 YEARS CONSIDERED 27
1.5 CURRENCY CONSIDERED 27
1.6 STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 34
2.2 MARKET SIZE ESTIMATION 36
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 41
2.4 MARKET SHARE ESTIMATION 42
2.5 STUDY ASSUMPTIONS 42
2.6 LIMITATIONS 42
2.6.1 METHODOLOGY-RELATED LIMITATIONS 43
2.7 RISK ASSESSMENT 43
2.8 IMPACT OF RECESSION ON PREFILLED SYRINGES MARKET 43
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 50
4.1 PREFILLED SYRINGES MARKET OVERVIEW 50
4.2 ASIA PACIFIC: PREFILLED SYRINGES MARKET OVERVIEW 51
4.3 PREFILLED SYRINGES MARKET: REGIONAL MIX 52
4.4 PREFILLED SYRINGES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 53
4.5 PREFILLED SYRINGES MARKET: DEVELOPED VS. EMERGING ECONOMIES 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing prevalence of chronic diseases 56
5.2.1.2 Growing adoption of self-injection devices 56
5.2.1.3 Increasing adoption of prefilled syringes in parenteral dosage forms 57
5.2.1.4 Increased use of biologics and vaccines 58
5.2.1.5 Technological advancements in prefilled syringes 58
5.2.2 RESTRAINTS 59
5.2.2.1 Stringent government regulations 59
5.2.2.2 Impact of product recalls 59
5.2.3 OPPORTUNITIES 60
5.2.3.1 Growing preference for unit-dose medication using prefilled syringes 60
5.2.3.2 Emerging markets with growing healthcare infrastructure 60
5.2.4 CHALLENGES 61
5.2.4.1 Alternative drug delivery methods 61
5.2.4.2 Infections associated with needlestick injuries 62
5.3 INDUSTRY TRENDS 62
5.3.1 PREFILLED BIOLOGICS 62
5.3.2 INTEGRATED SAFETY FEATURES 63
5.4 TECHNOLOGY ANALYSIS 63
5.4.1 KEY TECHNOLOGIES 63
5.4.1.1 Integration disinfection unit (IDU) 63
5.4.2 COMPLEMENTARY TECHNOLOGIES 64
5.4.2.1 Cyclic olefin polymers (COP) and cyclic olefin copolymers (COC) 64
5.4.3 ADJACENT TECHNOLOGIES 64
5.4.3.1 Integration with autoinjectors 64
5.5 VALUE CHAIN ANALYSIS 65
5.6 PORTER’S FIVE FORCES ANALYSIS 66
5.6.1 THREAT OF NEW ENTRANTS 67
5.6.2 THREAT OF SUBSTITUTES 67
5.6.3 BARGAINING POWER OF SUPPLIERS 67
5.6.4 BARGAINING POWER OF BUYERS 67
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 67
5.7 REGULATORY LANDSCAPE 68
5.7.1 REGULATORY ANALYSIS 68
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
5.8 CASE STUDY ANALYSIS 71
5.8.1 CASE STUDY 1: ENVIRONMENTAL BENEFITS OF USING PREFILLED ‘EMERGENCY’ DRUGS 71
5.8.2 CASE STUDY 2: DEVELOPMENT OF NOVEL PHARMACEUTICAL DRUG MODALITIES REQUIRING FROZEN STORAGE AND TRANSPORTATION 72
5.9 PRICING ANALYSIS 72
5.9.1 AVERAGE SELLING PRICE OF PREFILLED SYRINGES, BY TYPE, 2022–2024 72
5.9.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 73
5.10 UNMET NEEDS 73
5.11 ECOSYSTEM ANALYSIS 74
5.12 SUPPLY CHAIN ANALYSIS 75
5.13 ADJACENT MARKET ANALYSIS 76
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
5.15 TRADE ANALYSIS 78
5.16 PATENT ANALYSIS 79
5.16.1 PATENT PUBLICATION TRENDS FOR PREFILLED SYRINGES 79
5.16.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 80
5.16.3 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PREFILLED SYRINGE PATENTS (JANUARY 2014−APRIL 2024) 81
5.16.4 TOP APPLICANT COUNTRIES/REGIONS PATENTS FOR PREFILLED SYRINGES (JANUARY 2014−APRIL 2024) 81
5.17 KEY CONFERENCES & EVENTS DURING 2024–2025 83
5.18 KEY STAKEHOLDERS & BUYING CRITERIA 84
5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
5.18.2 BUYING CRITERIA 85
5.19 INVESTMENT & FUNDING SCENARIO 86
5.20 REIMBURSEMENT SCENARIO 86
5.21 MARKET ANALYSIS OF PREFILLED SYRINGE COMPONENTS 87
5.21.1 PLUNGER STOPPERS 87
6 PREFILLED SYRINGES MARKET, BY TYPE 89
6.1 INTRODUCTION 90
6.2 CONVENTIONAL PREFILLED SYRINGES 90
6.2.1 DISPOSABLE PREFILLED SYRINGES 93
6.2.1.1 Increasing focus on patient safety to drive market 93
6.2.2 REUSABLE PREFILLED SYRINGES 95
6.2.2.1 Cost-effectiveness and technological advancements to drive market 95
6.3 SAFETY PREFILLED SYRINGES 97
6.3.1 INTEGRATED SAFETY FEATURES TO BOOST ADOPTION 97
7 PREFILLED SYRINGES MARKET, BY DESIGN 99
7.1 INTRODUCTION 100
7.2 SINGLE-CHAMBER PREFILLED SYRINGES 100
7.2.1 CONVENIENCE, SAFETY, AND EFFICIENCY OF SINGLE-CHAMBER SYRINGES TO SUPPORT MARKET GROWTH 100
7.3 DUAL-CHAMBER PREFILLED SYRINGES 102
7.3.1 UNIQUE ADVANTAGES AND SPECIFIC APPLICATIONS OF DUAL-CHAMBER SYRINGES TO DRIVE DEMAND 102
7.4 CUSTOMIZED PREFILLED SYRINGES 104
7.4.1 PATIENT-FRIENDLY FEATURES SUCH AS EASY-TO-READ DOSAGE INDICATORS AND SAFETY MECHANISMS TO BOOST ADOPTION 104
8 PREFILLED SYRINGES MARKET, BY MATERIAL 106
8.1 INTRODUCTION 107
8.2 GLASS PREFILLED SYRINGES 107
8.2.1 ABILITY OF GLASS PREFILLED SYRINGES TO OFFER SUPERIOR BARRIER PROPERTIES TO BOOST MARKET GROWTH 107
8.3 PLASTIC PREFILLED SYRINGES 109
8.3.1 IMPROVED SAFETY, COST-EFFECTIVENESS, VERSATILITY, AND CONVENIENCE OF PLASTIC SYRINGES TO SUPPORT ADOPTION 109
9 PREFILLED SYRINGES MARKET, BY APPLICATION 111
9.1 INTRODUCTION 112
9.2 DIABETES 112
9.2.1 INCREASING PREVALENCE OF DIABETES TO FAVOR MARKET GROWTH 112
9.3 RHEUMATOID ARTHRITIS 114
9.3.1 RISING DEMAND FOR EFFECTIVE AND CONVENIENT TREATMENT OPTIONS FOR RHEUMATOID ARTHRITIS TO DRIVE MARKET 114
9.4 ANAPHYLAXIS 115
9.4.1 CONVENIENCE OF PREFILLED SYRINGES TO ADMINISTER MEDICATION QUICKLY DURING ANAPHYLACTIC EPISODES TO BOOST GROWTH 115
9.5 CANCER 117
9.5.1 RISING GLOBAL CANCER RATES TO SUPPORT MARKET GROWTH 117
9.6 THROMBOSIS 119
9.6.1 MINIMIZED RISK OF CONTAMINATION AND INFECTION ASSOCIATED WITH PREFILLED SYRINGES TO DRIVE DEMAND 119
9.7 OPHTHALMOLOGY 121
9.7.1 FEWER SIDE-EFFECTS ASSOCIATED WITH PREFILLED SYRINGES COMPARED TO TOPICAL MEDICATIONS TO SUPPORT GROWTH 121
9.8 OTHER APPLICATIONS 122
10 PREFILLED SYRINGES MARKET, BY REGION 123
10.1 INTRODUCTION 124
10.2 NORTH AMERICA 125
10.2.1 NORTH AMERICA: RECESSION IMPACT 126
10.2.2 US 130
10.2.2.1 US to dominate North American prefilled syringes market 130
10.2.3 CANADA 133
10.2.3.1 Increasing government support and rising incidence of chronic diseases to drive market 133
10.3 EUROPE 136
10.3.1 EUROPE: RECESSION IMPACT 138
10.3.2 GERMANY 140
10.3.2.1 Germany to dominate market in Europe 140
10.3.3 UK 143
10.3.3.1 Growing number of CVD and diabetes patients to drive market growth 143
10.3.4 FRANCE 146
10.3.4.1 Increasing needlestick injuries and growing trend of self-administration to drive market growth 146
10.3.5 SPAIN 149
10.3.5.1 Increase in biologics production to support market growth 149
10.3.6 ITALY 152
10.3.6.1 Growing focus of pharmaceutical and medical device companies to boost market growth 152
10.3.7 REST OF EUROPE (ROE) 155
10.4 ASIA PACIFIC 158
10.4.1 ASIA PACIFIC: RECESSION IMPACT 162
10.4.2 JAPAN 163
10.4.2.1 Increased geriatric population and favorable government initiatives to drive market growth in Japan 163
10.4.3 CHINA 165
10.4.3.1 Rising prevalence of chronic diseases to augment market growth 165
10.4.4 INDIA 168
10.4.4.1 High incidence of cancer and increased adoption of biosimilars to fuel market growth 168
10.4.5 AUSTRALIA 171
10.4.5.1 Growing healthcare expenditure to aid market growth 171
10.4.6 SOUTH KOREA 174
10.4.6.1 Well-developed healthcare sector and presence of major pharmaceutical manufacturers to drive market 174
10.4.7 REST OF ASIA PACIFIC 177
10.5 LATIN AMERICA 180
10.5.1 LATIN AMERICA: RECESSION IMPACT 180
10.5.2 BRAZIL 183
10.5.2.1 Rising incidence of chronic diseases and increasing obesity to augment market growth 183
10.5.3 MEXICO 186
10.5.3.1 Increasing focus of government on healthcare and growing medical tourism to propel market 186
10.5.4 ARGENTINA 188
10.5.4.1 Increasing focus of government on healthcare and growing medical tourism to propel market 188
10.5.5 REST OF LATIN AMERICA 191
10.6 MIDDLE EAST & AFRICA 194
10.6.1 GROWING PUBLIC HEALTHCARE SPENDING TO BOOST MARKET 194
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 194
10.7 GCC COUNTRIES 197
10.7.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET 197
10.7.2 GCC COUNTRIES: RECESSION IMPACT 197
11 COMPETITIVE LANDSCAPE 200
11.1 OVERVIEW 200
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 200
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PREFILLED
SYRINGES MARKET 201
11.3 REVENUE ANALYSIS 202
11.4 MARKET SHARE ANALYSIS 203
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 205
11.5.1 STARS 205
11.5.2 EMERGING LEADERS 205
11.5.3 PERVASIVE PLAYERS 205
11.5.4 PARTICIPANTS 205
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 207
11.5.5.1 Company footprint 207
11.5.5.2 Type footprint 208
11.5.5.3 Material footprint 209
11.5.5.4 Design footprint 210
11.5.5.5 Application footprint 211
11.5.5.6 Region footprint 212
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 213
11.6.1 PROGRESSIVE COMPANIES 213
11.6.2 RESPONSIVE COMPANIES 213
11.6.3 DYNAMIC COMPANIES 213
11.6.4 STARTING BLOCKS 213
11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023 215
11.7 BRAND/PRODUCT COMPARISON 216
11.7.1 BD 217
11.7.2 GERRESHEIMER AG 217
11.7.3 STEVANATO GROUP 217
11.7.4 SCHOTT GROUP 217
11.7.5 NIPRO 217
11.8 R&D EXPENDITURE 218
11.9 COMPETITIVE SITUATION 218
11.9.1 PRODUCT LAUNCHES 218
11.9.2 DEALS 220
11.9.3 EXPANSIONS 224
11.10 COMPANY VALUATION & FINANCIAL METRICS 228
12 COMPANY PROFILES 229
12.1 KEY PLAYERS 229
12.1.1 BD 229
12.1.1.1 Business overview 229
12.1.1.2 Products offered 230
12.1.1.3 Recent developments 233
12.1.1.3.1 Product launches & approvals 233
12.1.1.3.2 Deals 233
12.1.1.3.3 Expansions 234
12.1.1.4 MnM view 235
12.1.1.4.1 Right to win 235
12.1.1.4.2 Strategic choices 235
12.1.1.4.3 Weaknesses & competitive threats 235
12.1.2 GERRESHEIMER AG 236
12.1.2.1 Business overview 236
12.1.2.2 Products offered 237
12.1.2.3 Recent developments 238
12.1.2.3.1 Deals 238
12.1.2.3.2 Expansions 239
12.1.2.4 MnM view 239
12.1.2.4.1 Right to win 239
12.1.2.4.2 Strategic choices 239
12.1.2.4.3 Weaknesses & competitive threats 239
12.1.3 SCHOTT 240
12.1.3.1 Business overview 240
12.1.3.2 Products offered 241
12.1.3.3 Recent developments 242
12.1.3.3.1 Expansions 242
12.1.3.4 MnM view 243
12.1.3.4.1 Right to win 243
12.1.3.4.2 Strategic choices 243
12.1.3.4.3 Weaknesses & competitive threats 243
12.1.4 WEST PHARMACEUTICAL SERVICES, INC. 244
12.1.4.1 Business overview 244
12.1.4.2 Products offered 245
12.1.4.3 Recent developments 246
12.1.4.3.1 Deals 246
12.1.4.3.2 Expansions 247
12.1.5 APTARGROUP, INC. 248
12.1.5.1 Business overview 248
12.1.5.2 Products offered 249
12.1.5.3 Recent developments 250
12.1.5.3.1 Deals 250
12.1.5.3.2 Expansions 250
12.1.6 NIPRO 252
12.1.6.1 Business overview 252
12.1.6.2 Products offered 254
12.1.7 BAXTER (SIMTRA) 255
12.1.7.1 Business overview 255
12.1.7.2 Products offered 256
12.1.7.3 Recent developments 256
12.1.7.3.1 Deals 256
12.1.7.3.2 Expansions 257
12.1.8 OWEN MUMFORD LTD. 258
12.1.8.1 Business overview 258
12.1.8.2 Products offered 258
12.1.8.3 Recent developments 259
12.1.8.3.1 Product launches 259
12.1.8.3.2 Deals 259
12.1.9 WEIGAO MEDICAL INTERNATIONAL CO., LTD 260
12.1.9.1 Business overview 260
12.1.9.2 Products offered 261
12.1.10 CREDENCE MEDSYSTEMS, INC. 262
12.1.10.1 Business overview 262
12.1.10.2 Products offered 262
12.1.11 NOVARTIS AG 263
12.1.11.1 Business overview 263
12.1.11.2 Products offered 264
12.1.11.3 Recent developments 265
12.1.11.3.1 Deals 265
12.1.12 STEVANATO GROUP 266
12.1.12.1 Business overview 266
12.1.12.2 Products offered 267
12.1.12.3 Recent developments 268
12.1.12.3.1 Product launches 268
12.1.12.3.2 Deals 269
12.1.12.3.3 Expansions 270
12.1.13 POLYMEDICURE 271
12.1.13.1 Business overview 271
12.1.13.2 Products offered 272
12.1.14 MEDXL INC. 273
12.1.14.1 Business overview 273
12.1.14.2 Products offered 273
12.1.15 SHARPS TECHNOLOGY, INC. 274
12.1.15.1 Business overview 274
12.1.15.2 Products offered 274
12.2 OTHER PLAYERS 275
12.2.1 FRESENIUS KABI USA 275
12.2.2 MEDEFIL, INC. 276
12.2.3 D.B.M. S.R.L. 277
12.2.4 TAISEI KAKO CO., LTD. 278
12.2.5 SHANDONG PROVINCE MEDICINAL GLASS CO., LTD. 279
12.2.6 SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD. 280
12.2.7 J.O. PHARMA CO., LTD. (OTSUKA HOLDINGS CO., LTD.) 281
12.2.8 BMI KOREA 281
12.2.9 B. BRAUN SE 282
12.2.10 AL SHIFA MEDICAL PRODUCTS CO. 283
13 APPENDIX 284
13.1 DISCUSSION GUIDE 284
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 289
13.3 CUSTOMIZATION OPTIONS 291
13.4 RELATED REPORTS 291
13.5 AUTHOR DETAILS 292
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES 27
TABLE 2 RISK ASSESSMENT: PREFILLED SYRINGES MARKET 43
TABLE 3 PREFILLED SYRINGES MARKET: PORTER’S FIVE FORCES ANALYSIS 66
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 9 AVERAGE SELLING PRICE OF PREFILLED SYRINGES, BY TYPE, 2022–2024 (USD) 72
TABLE 10 AVERAGE SELLING PRICE OF CONVENTIONAL PREFILLED SYRINGES, BY REGION, 2022–2024 (USD) 73
TABLE 11 AVERAGE SELLING PRICE OF SAFETY PREFILLED SYRINGES, BY REGION,
2022–2024 (USD) 73
TABLE 12 PREFILLED SYRINGES MARKET: ECOSYSTEM ANALYSIS 74
TABLE 13 IMPORT DATA FOR PREFILLED SYRINGES (HS CODE 90183100), BY COUNTRY, 2019–2023 (USD THOUSAND) 78
TABLE 14 EXPORT DATA FOR PREFILLED SYRINGES (HS CODE 90183100), BY COUNTRY, 2019–2023 (USD THOUSAND) 79
TABLE 15 LIST OF PATENTS IN PREFILLED SYRINGES MARKET (2022−2024) 82
TABLE 16 PREFILLED SYRINGES MARKET: KEY CONFERENCES & EVENTS (2024–2025) 83
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PREFILLED SYRINGES 84
TABLE 18 KEY BUYING CRITERIA FOR PREFILLED SYRINGES 85
TABLE 19 PRODUCT ANALYSIS OF KEY PLAYERS IN PREFILLED SYRINGE COMPONENTS 88
TABLE 20 PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 90
TABLE 21 CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 91
TABLE 22 CONVENTIONAL PREFILLED SYRINGES MARKET, BY REGION,
2022–2030 (MILLION UNITS) 91
TABLE 23 CONVENTIONAL PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 92
TABLE 24 DISPOSABLE PREFILLED SYRINGES MARKET, BY REGION,
2022–2030 (MILLION UNITS) 93
TABLE 25 DISPOSABLE PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 94
TABLE 26 REUSABLE PREFILLED SYRINGES MARKET, BY REGION,
2022–2030 (MILLION UNITS) 95
TABLE 27 REUSABLE PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 96
TABLE 28 SAFETY PREFILLED SYRINGES MARKET, BY REGION, 2022–2030 (MILLION UNITS) 97
TABLE 29 SAFETY PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98
TABLE 30 PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 100
TABLE 31 SINGLE-CHAMBER PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 101
TABLE 32 DUAL-CHAMBER PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 103
TABLE 33 CUSTOMIZED PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 105
TABLE 34 PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 107
TABLE 35 GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 108
TABLE 36 PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 110
TABLE 37 PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 112
TABLE 38 PREFILLED SYRINGES MARKET FOR DIABETES APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 39 PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 40 PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 116
TABLE 41 PREFILLED SYRINGES MARKET FOR CANCER APPLICATIONS, BY COUNTRY,
2022–2030 (USD MILLION) 118
TABLE 42 PREFILLED SYRINGES MARKET FOR THROMBOSIS APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 120
TABLE 43 PREFILLED SYRINGES MARKET FOR OPHTHALMOLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 121
TABLE 44 PREFILLED SYRINGES MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2022–2030 (USD MILLION) 122
TABLE 45 PREFILLED SYRINGES MARKET, BY REGION, 2022–2030 (USD MILLION) 125
TABLE 46 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 128
TABLE 47 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 128
TABLE 48 NORTH AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 128
TABLE 49 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 129
TABLE 50 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 129
TABLE 51 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 130
TABLE 52 US: KEY MACROINDICATORS 131
TABLE 53 US: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 131
TABLE 54 US: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 131
TABLE 55 US: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 132
TABLE 56 US: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 132
TABLE 57 US: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 133
TABLE 58 CANADA: KEY MACROINDICATORS 134
TABLE 59 CANADA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 134
TABLE 60 CANADA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 134
TABLE 61 CANADA: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 135
TABLE 62 CANADA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 135
TABLE 63 CANADA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 136
TABLE 64 EUROPE: PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 138
TABLE 65 EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 138
TABLE 66 EUROPE: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 139
TABLE 67 EUROPE: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 139
TABLE 68 EUROPE: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 139
TABLE 69 EUROPE: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 140
TABLE 70 GERMANY: KEY MACROINDICATORS 141
TABLE 71 GERMANY: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 141
TABLE 72 GERMANY: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 141
TABLE 73 GERMANY: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 142
TABLE 74 GERMANY: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 142
TABLE 75 GERMANY: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 143
TABLE 76 UK: KEY MACROINDICATORS 144
TABLE 77 UK: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 144
TABLE 78 UK: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 144
TABLE 79 UK: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 145
TABLE 80 UK: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 145
TABLE 81 UK: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 146
TABLE 82 FRANCE: KEY MACROINDICATORS 147
TABLE 83 FRANCE: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 147
TABLE 84 FRANCE: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 148
TABLE 85 FRANCE: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 148
TABLE 86 FRANCE: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 148
TABLE 87 FRANCE: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 149
TABLE 88 SPAIN: KEY MACROINDICATORS 150
TABLE 89 SPAIN: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 150
TABLE 90 SPAIN: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 150
TABLE 91 SPAIN: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 151
TABLE 92 SPAIN: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 151
TABLE 93 SPAIN: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 152
TABLE 94 ITALY: KEY MACROINDICATORS 153
TABLE 95 ITALY: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 153
TABLE 96 ITALY: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 153
TABLE 97 ITALY: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 154
TABLE 98 ITALY: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 154
TABLE 99 ITALY: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 155
TABLE 100 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 155
TABLE 101 REST OF EUROPE: CONVENTIONAL PREFILLED SYRINGES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 156
TABLE 102 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 156
TABLE 103 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 157
TABLE 104 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 157
TABLE 105 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 160
TABLE 106 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 160
TABLE 107 ASIA PACIFIC: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 161
TABLE 108 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 161
TABLE 109 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 161
TABLE 110 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 162
TABLE 111 JAPAN: KEY MACROINDICATORS 163
TABLE 112 JAPAN: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 163
TABLE 113 JAPAN: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 164
TABLE 114 JAPAN: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 164
TABLE 115 JAPAN: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 164
TABLE 116 JAPAN: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 165
TABLE 117 CHINA: KEY MACROINDICATORS 166
TABLE 118 CHINA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 166
TABLE 119 CHINA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 166
TABLE 120 CHINA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 167
TABLE 121 CHINA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 167
TABLE 122 CHINA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 168
TABLE 123 INDIA: KEY MACROINDICATORS 169
TABLE 124 INDIA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 169
TABLE 125 INDIA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 169
TABLE 126 INDIA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 170
TABLE 127 INDIA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 170
TABLE 128 INDIA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 171
TABLE 129 AUSTRALIA: KEY MACROINDICATORS 172
TABLE 130 AUSTRALIA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 172
TABLE 131 AUSTRALIA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 172
TABLE 132 AUSTRALIA: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 173
TABLE 133 AUSTRALIA: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 173
TABLE 134 AUSTRALIA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 174
TABLE 135 SOUTH KOREA: KEY MACROINDICATORS 175
TABLE 136 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 175
TABLE 137 SOUTH KOREA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 175
TABLE 138 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 176
TABLE 139 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 176
TABLE 140 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 177
TABLE 141 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 177
TABLE 142 REST OF ASIA PACIFIC: CONVENTIONAL PREFILLED SYRINGES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 178
TABLE 143 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 178
TABLE 144 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 179
TABLE 145 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 179
TABLE 146 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 180
TABLE 147 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 181
TABLE 148 LATIN AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 181
TABLE 149 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 181
TABLE 150 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 182
TABLE 151 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 182
TABLE 152 BRAZIL: KEY MACROINDICATORS 183
TABLE 153 BRAZIL: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 184
TABLE 154 BRAZIL: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 184
TABLE 155 BRAZIL: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022–2030 (USD MILLION) 184
TABLE 156 BRAZIL: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 185
TABLE 157 BRAZIL: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 185
TABLE 158 MEXICO: KEY MACROINDICATORS 186
TABLE 159 MEXICO: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 187
TABLE 160 MEXICO: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 187
TABLE 161 MEXICO: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 187
TABLE 162 MEXICO: PREFILLED SYRINGES MARKET, BY DESIGN, 2022–2030 (USD MILLION) 188
TABLE 163 MEXICO: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 188
TABLE 164 ARGENTINA: KEY MACROINDICATORS 189
TABLE 165 ARGENTINA: PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 189
TABLE 166 ARGENTINA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 190
TABLE 167 ARGENTINA: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 190
TABLE 168 ARGENTINA: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 190
TABLE 169 ARGENTINA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 191
TABLE 170 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 192
TABLE 171 REST OF LATIN AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 192
TABLE 172 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 192
TABLE 173 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 193
TABLE 174 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 193
TABLE 175 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 194
TABLE 176 MIDDLE EAST & AFRICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022–2030 (USD MILLION) 195
TABLE 177 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 195
TABLE 178 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 196
TABLE 179 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 196
TABLE 180 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 197
TABLE 181 GCC COUNTRIES: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2022–2030 (USD MILLION) 198
TABLE 182 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY MATERIAL,
2022–2030 (USD MILLION) 198
TABLE 183 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY DESIGN,
2022–2030 (USD MILLION) 199
TABLE 184 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 199
TABLE 185 PREFILLED SYRINGES MARKET: DEGREE OF COMPETITION 204
TABLE 186 PREFILLED SYRINGES MARKET: TYPE FOOTPRINT 208
TABLE 187 PREFILLED SYRINGES MARKET: MATERIAL FOOTPRINT 209
TABLE 188 PREFILLED SYRINGES MARKET: DESIGN FOOTPRINT 210
TABLE 189 PREFILLED SYRINGES MARKET: APPLICATION FOOTPRINT 211
TABLE 190 PREFILLED SYRINGES MARKET: REGION FOOTPRINT 212
TABLE 191 PREFILLED SYRINGES MARKET: DETAILED LIST OF KEY START-UPS/SMES 215
TABLE 192 PREFILLED SYRINGES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS 215
TABLE 193 PREFILLED SYRINGES MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 218
TABLE 194 PREFILLED SYRINGES MARKET: DEALS, JANUARY 2021–JUNE 2024 220
TABLE 195 PREFILLED SYRINGES MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024 224
TABLE 196 BD: COMPANY OVERVIEW 229
TABLE 197 BD: PRODUCTS OFFERED 230
TABLE 198 BD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2024 233
TABLE 199 BD: DEALS, JANUARY 2021–JUNE 2024 233
TABLE 200 BD: EXPANSIONS, JANUARY 2021–JUNE 2024 234
TABLE 201 GERRESHEIMER AG: COMPANY OVERVIEW 236
TABLE 202 GERRESHEIMER AG: PRODUCTS OFFERED 237
TABLE 203 GERRESHEIMER AG: DEALS, JANUARY 2021–JUNE 2024 238
TABLE 204 GERRESHEIMER AG: EXPANSIONS, JANUARY 2021–JUNE 2024 239
TABLE 205 SCHOTT: COMPANY OVERVIEW 240
TABLE 206 SCHOTT: PRODUCTS OFFERED 241
TABLE 207 SCHOTT: EXPANSIONS, JANUARY 2021–JUNE 2024 242
TABLE 208 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW 244
TABLE 209 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS OFFERED 245
TABLE 210 WEST PHARMACEUTICAL SERVICES, INC.: DEALS, JANUARY 2021–JUNE 2024 246
TABLE 211 WEST PHARMACEUTICAL SERVICES, INC.: EXPANSIONS,
JANUARY 2021–JUNE 2024 247
TABLE 212 APTARGROUP, INC.: COMPANY OVERVIEW 248
TABLE 213 APTARGROUP, INC.: PRODUCTS OFFERED 249
TABLE 214 APTARGROUP, INC.: DEALS, JANUARY 2021–JUNE 2024 250
TABLE 215 APTARGROUP, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024 250
TABLE 216 NIPRO: COMPANY OVERVIEW 252
TABLE 217 NIPRO: PRODUCTS OFFERED 254
TABLE 218 BAXTER (SIMTRA): COMPANY OVERVIEW 255
TABLE 219 BAXTER (SIMTRA): PRODUCTS OFFERED 256
TABLE 220 BAXTER (SIMTRA): DEALS, JANUARY 2021–JUNE 2024 256
TABLE 221 BAXTER (SIMTRA): EXPANSIONS, JANUARY 2021–JUNE 2024 257
TABLE 222 OWEN MUMFORD LTD.: COMPANY OVERVIEW 258
TABLE 223 OWEN MUMFORD LTD.: PRODUCTS OFFERED 258
TABLE 224 OWEN MUMFORD LTD.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 259
TABLE 225 OWEN MUMFORD LTD.: DEALS, JANUARY 2021–JUNE 2024 259
TABLE 226 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: COMPANY OVERVIEW 260
TABLE 227 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: PRODUCTS OFFERED 261
TABLE 228 CREDENCE MEDSYSTEMS, INC.: COMPANY OVERVIEW 262
TABLE 229 CREDENCE MEDSYSTEMS, INC.: PRODUCTS OFFERED 262
TABLE 230 NOVARTIS AG: COMPANY OVERVIEW 263
TABLE 231 NOVARTIS AG: PRODUCTS OFFERED 264
TABLE 232 NOVARTIS AG: DEALS, JANUARY 2021–JUNE 2024 265
TABLE 233 STEVANATO GROUP: COMPANY OVERVIEW 266
TABLE 234 STEVANATO GROUP: PRODUCTS OFFERED 267
TABLE 235 STEVANATO GROUP: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 268
TABLE 236 STEVANATO GROUP: DEALS, JANUARY 2021–MARCH 2024 269
TABLE 237 STEVANATO GROUP: EXPANSIONS, JANUARY 2021–JUNE 2024 270
TABLE 238 POLYMEDICURE: COMPANY OVERVIEW 271
TABLE 239 POLYMEDICURE: PRODUCTS OFFERED 272
TABLE 240 MEDXL INC.: COMPANY OVERVIEW 273
TABLE 241 MEDXL INC.: PRODUCTS OFFERED 273
TABLE 242 SHARPS TECHNOLOGY, INC.: COMPANY OVERVIEW 274
TABLE 243 SHARPS TECHNOLOGY, INC.: PRODUCTS OFFERED 274
LIST OF FIGURES
FIGURE 1 PREFILLED SYRINGES MARKET SEGMENTATION 26
FIGURE 2 RESEARCH DESIGN 30
FIGURE 3 PRIMARY SOURCES 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 35
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 35
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BD (2023) 37
FIGURE 9 PREFILLED SYRINGES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (2023) 38
FIGURE 10 PREFILLED SYRINGES MARKET: TOP-DOWN APPROACH 38
FIGURE 11 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS (2024–2030) 40
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 13 DATA TRIANGULATION METHODOLOGY 41
FIGURE 14 PREFILLED SYRINGES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION) 45
FIGURE 15 CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE,
2024 VS. 2030 (USD MILLION) 46
FIGURE 16 PREFILLED SYRINGES MARKET, BY MATERIAL, 2024 VS. 2030 (USD MILLION) 46
FIGURE 17 PREFILLED SYRINGES MARKET, BY DESIGN, 2024 VS. 2030 (USD MILLION) 47
FIGURE 18 PREFILLED SYRINGES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 48
FIGURE 19 GEOGRAPHIC SNAPSHOT OF PREFILLED SYRINGES MARKET 49
FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE GROWTH IN PREFILLED SYRINGES MARKET 50
FIGURE 21 CONVENTIONAL PREFILLED SYRINGES ACCOUNTED FOR LARGEST SHARE OF APAC PREFILLED SYRINGES MARKET IN 2023 51
FIGURE 22 NORTH AMERICA TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD 52
FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 53
FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 54
FIGURE 25 PREFILLED SYRINGES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
FIGURE 26 PREFILLED SYRINGES MARKET: VALUE CHAIN ANALYSIS 65
FIGURE 27 PREFILLED SYRINGES MARKET: PORTER’S FIVE FORCES ANALYSIS 66
FIGURE 28 PREFILLED SYRINGES MARKET: SUPPLY CHAIN ANALYSIS 76
FIGURE 29 ADJACENT MARKETS TO PREFILLED SYRINGES MARKET 76
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN PREFILLED SYRINGES MARKET 77
FIGURE 31 GLOBAL PATENT PUBLICATION TRENDS (JANUARY 2014–JUNE 2024) 80
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PREFILLED SYRINGES 84
FIGURE 33 KEY BUYING CRITERIA FOR PREFILLED SYRINGES, BY TYPE 85
FIGURE 34 INVESTMENT/VENTURE CAPITAL SCENARIO IN PREFILLED SYRINGES MARKET, 2021–2024 86
FIGURE 35 PREFILLED SYRINGES MARKET: GEOGRAPHIC SNAPSHOT 124
FIGURE 36 NORTH AMERICA: PREFILLED SYRINGES MARKET SNAPSHOT 127
FIGURE 37 EUROPE: PREFILLED SYRINGES MARKET SNAPSHOT 137
FIGURE 38 ASIA PACIFIC: PREFILLED SYRINGES MARKET SNAPSHOT 159
FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES 201
FIGURE 40 PREFILLED SYRINGES MARKET: REVENUE ANALYSIS, 2019–2023 202
FIGURE 41 PREFILLED SYRINGES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023 203
FIGURE 42 PREFILLED SYRINGES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 206
FIGURE 43 PREFILLED SYRINGES MARKET: COMPANY FOOTPRINT 207
FIGURE 44 PREFILLED SYRINGES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 214
FIGURE 45 PREFILLED SYRINGES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 216
FIGURE 46 R&D EXPENDITURE OF KEY PLAYERS, 2022 VS. 2023 218
FIGURE 47 EV/EBITDA OF KEY VENDORS 228
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 228
FIGURE 49 BD: COMPANY SNAPSHOT (2023) 230
FIGURE 50 GERRESHEIMER AG: COMPANY SNAPSHOT (2023) 237
FIGURE 51 SCHOTT: COMPANY SNAPSHOT (2023) 241
FIGURE 52 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2023) 245
FIGURE 53 APTARGROUP, INC.: COMPANY SNAPSHOT (2023) 249
FIGURE 54 NIPRO: COMPANY SNAPSHOT (2023) 253
FIGURE 55 BAXTER (SIMTRA): COMPANY SNAPSHOT (2023) 256
FIGURE 56 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: COMPANY SNAPSHOT (2023) 261
FIGURE 57 NOVARTIS AG: COMPANY SNAPSHOT (2023) 264
FIGURE 58 STEVANATO GROUP: COMPANY SNAPSHOT (2023) 267
FIGURE 59 POLYMEDICURE: COMPANY SNAPSHOT (2023) 272
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11